Live Earnings Conference Call: Jazz Pharmaceuticals will host a live Q3 2026 earnings call on November 2, 2026 at 5:30PM ET. Get details.

Jazz Pharmaceuticals (JAZZ) Earnings Date, Estimates & Call Transcripts

$215.55 -0.43 (-0.20%)

As of 10:22 AM Eastern

Compare

Jazz Pharmaceuticals Earnings Summary

Jazz Pharmaceuticals issued Q2 2026 earnings on August 3, 2026, reporting an EPS of $5.71, which missed analysts' consensus estimates of $6.18 by $0.47. Quarterly revenue rose 15.5% year-over-year to $1.21 billion, above the consensus estimate of $1.11 billion. With a trailing EPS of $14.50 and a P/E Ratio of 14.89, Jazz Pharmaceuticals' earnings are expected to grow 100.28% next year, from $10.87 to $21.77 per share.

Upcoming Q3 Earnings Date: Nov. 2Estimated
Consensus EPS (Aug. 3): $6.18
Actual EPS (Aug. 3): $5.71 Missed By -$0.47
Actual Revenue (Aug. 3): $1.21B

Q2 2026 Earnings Resources

JAZZ Upcoming Earnings

Jazz Pharmaceuticals' Q3 2026 earnings is estimated for Monday, November 2, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Q3 2026 Earnings Report

Slide Deck

Full Screen Slide Deck

Get Jazz Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jazz Pharmaceuticals and other key companies, straight to your inbox.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JAZZ Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

JAZZ Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Jazz Pharmaceuticals Upcoming Earnings Consensus

Report Date: November 2, 2026
Consensus EPS Estimate: -$4.05
Consensus Revenue Estimate: $1.21B

Jazz Pharmaceuticals Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2026	1	$3.62	$3.62	$3.62
Q2 2026	1	$5.24	$5.24	$5.24
Q3 2026	1	-$5.14	-$5.14	-$5.14
Q4 2026	1	$5.28	$5.28	$5.28
FY 2026	4	$9.00	$9.00	$9.00
Q1 2027	1	$4.30	$4.30	$4.30
Q2 2027	1	$5.44	$5.44	$5.44
Q3 2027	1	$5.16	$5.16	$5.16
Q4 2027	1	$5.11	$5.11	$5.11
FY 2027	4	$20.01	$20.01	$20.01
Q1 2028	1	$4.92	$4.92	$4.92
Q2 2028	1	$6.09	$6.09	$6.09

Jazz Pharmaceuticals Earnings History by Quarter

Report Date

0 Results

Export

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/2/2026 (Estimated)	-	-$4.05	-	-	-	$1.21B	-
8/3/2026	Q2 2026	$6.18	$5.71	-$0.47	$2.78	$1.11B	$1.21B
5/5/2026	Q1 2026	$4.67	$6.34	+$1.67	$4.43	$978.66M	$974.98M
3/31/2026	Q1 2026	-	$6.34	-	$4.43	-	$1.07B
2/25/2026	Q4 2025	$6.49	$6.64	+$0.15	$3.21	$1.17B	$1.20B
8/5/2025	Q2 2025	-$5.61	-$8.25	-$2.64	-$11.74	$1.05B	$1.05B
5/6/2025	Q1 2025	$4.65	$1.68	-$2.97	-$1.52	$984.16M	$897.84M

Jazz Pharmaceuticals Earnings - Frequently Asked Questions

Jazz Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 2nd, 2026 based off last year's report dates. Learn more on JAZZ's earnings history.

In the previous quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ) missed the analysts' consensus estimate of $6.18 by $0.47 with a reported earnings per share (EPS) of $5.71. Learn more on analysts' earnings estimate vs. JAZZ's actual earnings.

The conference call for Jazz Pharmaceuticals' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Jazz Pharmaceuticals' latest earnings report can be read online.
Read Transcript

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a recorded annual revenue of $4.27 billion.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a recorded net income of -$356.15 million. JAZZ has generated $14.50 earnings per share over the last four quarters.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a trailing price-to-earnings ratio of 14.90 and a forward price-to-earnings ratio of 19.87. The price/earnings-to-growth ratio is 0.43.

Jazz Pharmaceuticals' earnings are expected to grow from $10.87 per share to $21.77 per share in the next year, which is a 100.28% increase.

More Earnings Resources from MarketBeat

Related Companies

Earnings Tools

Latest Articles

Earnings data for NASDAQ:JAZZ is sourced from Fiscal.ai, with the most recent quarter reported on 8/3/2026. New results are added as companies report their earnings.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jazz Pharmaceuticals (JAZZ) Earnings Date, Estimates & Call Transcripts